1D
0.38%
-2.25%
1W
-6.38%
-1.27%
1M
-9.03%
-9.48%
YTD
-12.86%
-13.66%
1Y
132.66%
-5.18%
3Y
166.28%
27.63%
5Y
139.57%
50.14%
10Y
36.63%
190.41%
- Stock Absolute Returns
- India SENSEXAbsolute Returns
Total Returns (Price + Dividend) 
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-15.41%
0%
-15.41%
6 Months
8.56%
0%
8.56%
1 Year
132.66%
0%
132.66%
2 Years
100.19%
0%
100.19%
3 Years
166.28%
0%
166.28%
4 Years
140.37%
0%
140.37%
5 Years
139.57%
0%
139.57%
Concord Drugs for the last several years.
What is a Quartile?
Quartile analysis gives a quick view of the performance of the stock with its peers and with the overall market. Companies are bucketed in 4 Quartiles as per their total returns generated; with each quartile consisting of 25% of the companies in the category.
Example: If there are 20 companies in an industry, the top 5 return giving companies would be bucketed in 1st quartile, next 5 companies in 2nd quartile and so on
Return Quartiles - by Closest Peers 
Inconsistent Performance
Concord Drugs Ltd has not been a consistent performer in the last 1 year and longer periods
2
Quartile
QTD
-14.76%
1
Quartile
Sep-Dec
23.66%
1
Quartile
Sep-Dec
23.66%
1
Quartile
1Y
126.44%
1
Quartile
2025
117.05%
4
Quartile
2024
-36.37%
Click on any of the quartiles for detailed breakdown
Return Quartiles - by Industry 
Inconsistent Performance
Concord Drugs Ltd has not been a consistent performer in the last 1 year and longer periods
2
Quartile
QTD
-14.76%
1
Quartile
Sep-Dec
23.66%
1
Quartile
Sep-Dec
23.66%
1
Quartile
1Y
126.44%
1
Quartile
2025
117.05%
4
Quartile
2024
-36.37%
Click on any of the quartiles for detailed breakdown
Return Quartiles - by Market Cap 
Not enough Stock Price history for Quartile Analysis
Risk Adjusted Returns v/s 
Returns Beta
Beta has not been calculated since enough price history is not available






